Skip to main content

Table 5 Results by Autonomous Region

From: Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain

Region

Eligible population

Scenario without B/N combination Budget impact (€)

Scenario with B/N combination Budget impact (€)

Difference (€) with B/N vs. without B/N

  

1 st

2 nd

3 rd

1 st

2 nd

3 rd

1 st

2 nd

3 rd

Andalucia

17,637

19,440,146

18,100,409

17,937,671

19,626,710

18,223,440

18,067,201

186,563

123,031

129,530

Aragon

1,362

1,501,246

1,397,786

1,385,219

1,515,653

1,407,287

1,395,222

14,407

9,501

10,003

Asturias

3,289

3,625,256

3,375,418

3,345,070

3,660,047

3,398,361

3,369,225

34,791

22,943

24,155

Baleares

2,541

2,800,783

2,607,764

2,584,318

2,827,662

2,625,490

2,602,980

26,879

17,725

18,662

Canary Islands

5,063

5,580,624

5,196,029

5,149,313

5,634,180

5,231,348

5,186,497

53,556

35,318

37,184

Cantabria

795

876,278

815,888

808,553

884,688

821,434

814,392

8,409

5,546

5,839

Castilla La Mancha

2,226

2,453,579

2,284,488

2,263,948

2,447,125

2,300,016

2,280,297

23,547

15,528

16,348

Castilla León

4,197

4,626,087

4,307,275

4,268,549

4,670,483

4,336,553

4,299,373

44,396

29,277

30,824

Catalonia

7,922

8,731,918

8,130,149

8,057,052

8,815,717

8,185,411

8,115,233

83,799

55,262

58,181

Extremadura

1,683

1,855,064

1,727,221

1,711,691

1,872,867

1,738,961

1,724,052

17,803

11,740

12,360

Galicia

7,822

8,621,694

8,027,522

7,955,347

8,704,435

8,082,086

8,012,794

82,741

54,564

57,447

Madrid

9,606

10,588,084

9,858,396

9,769,761

10,689,696

9,925,405

9,840,309

101,612

67,009

70,549

Murcia

2,021

2,227,620

2,074,101

2,055,453

2,248,998

2,088,199

2,070,296

21,378

14,098

14,843

Navarra

799

880,687

819,994

812,621

889,139

825,567

818,489

8,452

5,574

5,868

Basque Country

2,633

2,902,189

2,702,182

2,677,887

2,930,041

2,720,549

2,697,224

27,852

18,367

19,337

La Rioja

762

839,904

782,021

774,990

847,965

787,337

780,587

8,060

5,315

5,596

Valencia

6,425

7,081,870

6,593,816

6,534,532

7,149,833

6,638,635

6,581,718

67,963

44,819

47,187

Ceuta

603

664,649

618,844

613,280

671,027

623,050

617,708

6,379

4,206

4,429

Melilla

425

468,451

436,167

432,245

472,946

439,131

435,367

4,496

2,965

3,121

  1. Total cost of AOT per patient was estimated at €1,102; €1,026 and €1,017 for the first, second and third year, respectively, in the scenario without B/N combination. Incremental total cost per patient comparing the inclusion of the B/N combination to the scenario where methadone was the only medication available, was €10.58, €6.98 and €7.34 in the first, second and third year, respectively. National budgetary impact by target population group for the 3 study years is shown in Table 4.
Back to article page

Health Economics Review

ISSN: 2191-1991

Contact us